In Paxil Fraud Scheme, Glaxo Pays The Price
GlaxoSmithKline PLC will fork over $14 million to U.S. states in order to settle allegations that the drug giant forced government health plans to pay inflated prices for its widely-used antidepressant...To view the full article, register now.
Already a subscriber? Click here to view full article